<DOC>
	<DOCNO>NCT01081912</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Hydrocodone Bitartrate controlled-release capsule subject chronic low back pain .</brief_summary>
	<brief_title>Phase 3 Study Hydrocodone Bitartrate Controlled-release Capsules Subjects With Chronic Low Back Pain</brief_title>
	<detailed_description>A randomized Phase 3 , placebo-controlled multi-center study evaluate safety , efficacy tolerability Hydrocodone Bitartrate controlled-release capsule subject chronic low back pain . Subjects go open-label conversion titration phase follow randomized double-blind treatment phase Hydrocodone ( HC ) -Controlled-Release ( CR ) v . Placebo . The trial consist Screening Phase ( 14 day ) , open-label Conversion Titration Phase ( 6 week ) , 12-week placebo-controlled Treatment Phase , 2-week Follow-Up Phone Call</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>Subjects must clinical diagnosis moderate severe chronic lower back pain ( CLBP ) Subjects must classify nonneuropathic , neuropathic , symptomatic 6 month low back pain ( LBP ) surgery Subjects must Investigator 's opinion qualify aroundtheclock opioid therapy treatment chronic lower back pain ( CLBP ) . Subjects must take opioids least 5 days/week past 4weeks Subjects must average Clinic Pain Score â‰¥ 4 11point ( 010 ) numeric rating scale ( NRS ) average last 24 hour Screening Subjects , opinion Investigator , must consider generally good health CLBP Screening Female subject childbearing potential must negative urine pregnancy test Screening Visit , must consent use medicallyacceptable method contraception throughout entire study period . Subjects must voluntarily provide write informed consent . Any clinically significant condition would , opinion Investigator , preclude study participation interfere assessment pain symptom CLBP increase risk opioidrelated adverse event A medical condition , opinion Investigator , would compromise subject 's ability swallow , absorb , metabolize , excrete study drug A surgical procedure back pain within 6 month A nerve plexus block , include epidural steroid injection facet block A history chemotherapy confirm malignancy within past 2 year Any chronic pain condition CLBP , Investigator 's opinion , would interfere assessment LBP e.g . fibromyalgia , osteoarthritis , rheumatoid arthritis , migraine headache require opioid treatment Uncontrolled blood pressure , i.e. , subject sit systolic blood pressure &gt; 180 mmHg &lt; 90 mmHg , and/or sit diastolic blood pressure &gt; 120 mmHg &lt; 50 mmHg Screening A Body Mass Index ( BMI ) &gt; 45 kg/m2 A Hospital Anxiety Depression Scale ( HADS ) Index score &gt; 12 either depression anxiety subscales establish history major depressive disorder poorly control medication A clinically significant abnormality clinical chemistry , hematology urinalysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>back pain</keyword>
</DOC>